Literature DB >> 22004957

The genome-wide expression profile of gastric epithelial cells infected by naturally occurring cagA isogenic strains of Helicobacter pylori.

Sung-Hwa Sohn1, Yong-Chan Lee.   

Abstract

Helicobacter pylori (H. pylori) is associated with the development of gastric adenocarcinoma and lymphoma. However, the mechanisms through which H. pylori induces gastric mucosal lesions are not well defined. This study was conducted to evaluate the effect of the oncoprotein CagA on gastric cancer cells using whole-genome expression arrays. Human gastric epithelial (AGS) cells were incubated with CagA-positive H. pylori strains (147C (phosphorylated CagA) or 147A (dephosphorylated CagA)), and total protein and RNA were collected. The effects of phosphorylated and unphosphorylated CagA on AGS cells were then evaluated using Western blotting and microarray analysis. The expression levels of the genome profiles of AGS cells infected with 147A were compared with those of AGS cells infected with 147C. The expression profiles of the differentially expressed genes were grouped, and their expression patterns were validated via quantitative real-time PCR. Up- and down-regulated genes mainly included epithelial mesenchymal transition (EMT)-related genes. The results of the microarray analysis revealed that phosphorylated and unphosphorylated CagA may affect EMT in part through gene expression. This suggests that the intracellularly translocated CagA may be involved in EMT, resulting in differential expression of genes independent on the phosphorylation status of CagA.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22004957     DOI: 10.1016/j.etap.2011.08.006

Source DB:  PubMed          Journal:  Environ Toxicol Pharmacol        ISSN: 1382-6689            Impact factor:   4.860


  9 in total

1.  Curcuma wenyujin Y. H. Chen et C. Ling n-Butyl Alcohol Extract Inhibits AGS Cell Helicobacter pyloriCagA+VacA+ Promoted Invasiveness by Down-Regulating Caudal Type Homeobox Transcription Factor and Claudin-2 Expression.

Authors:  Hai-Feng Jin; Jin-Feng Dai; Li-Na Meng; Bin Lu
Journal:  Chin J Integr Med       Date:  2017-08-17       Impact factor: 1.978

Review 2.  Polymorphism in the Helicobacter pylori CagA and VacA toxins and disease.

Authors:  Dacie R Bridge; D Scott Merrell
Journal:  Gut Microbes       Date:  2013-02-04

Review 3.  Helicobacter pylori infection: host immune response, implications on gene expression and microRNAs.

Authors:  Aline Cristina Targa Cadamuro; Ana Flávia Teixeira Rossi; Nathália Maciel Maniezzo; Ana Elizabete Silva
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

4.  Comparative genomic study of gastric epithelial cells co-cultured with Helicobacter pylori.

Authors:  Fen Wang; Li-Dan Luo; Jian-Hua Pan; Li-Hua Huang; Hong-Wei Lv; Qin Guo; Can-Xia Xu; Shou-Rong Shen
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

5.  Interleukin-8 is the single most up-regulated gene in whole genome profiling of H. pylori exposed gastric epithelial cells.

Authors:  Lars L Eftang; Ying Esbensen; Tone M Tannæs; Ida R K Bukholm; Geir Bukholm
Journal:  BMC Microbiol       Date:  2012-01-17       Impact factor: 3.605

6.  Helicobacter pylori promotes epithelial-mesenchymal transition in gastric cancer by downregulating programmed cell death protein 4 (PDCD4).

Authors:  Han Yu; Jiping Zeng; Xiuming Liang; Wenfu Wang; Yabin Zhou; Yundong Sun; Shili Liu; Wenjuan Li; Chunyan Chen; Jihui Jia
Journal:  PLoS One       Date:  2014-08-21       Impact factor: 3.240

7.  Membrane Proteocomplexome of Campylobacter jejuni Using 2-D Blue Native/SDS-PAGE Combined to Bioinformatics Analysis.

Authors:  Alizée Guérin; Sheiam Sulaeman; Laurent Coquet; Armelle Ménard; Frédérique Barloy-Hubler; Emmanuelle Dé; Odile Tresse
Journal:  Front Microbiol       Date:  2020-11-19       Impact factor: 5.640

8.  RNF43 and PWWP2B inhibit cancer cell proliferation and are predictive or prognostic biomarker for FDA-approved drugs in patients with advanced gastric cancer.

Authors:  Sung-Hwa Sohn; Hee Jung Sul; Bohyun Kim; Hyeong Su Kim; Bum Jun Kim; Hyun Lim; Ho Suk Kang; Jae Seung Soh; Kab Choong Kim; Ji Woong Cho; Jinwon Seo; Youngho Koh; Dae Young Zang
Journal:  J Cancer       Date:  2021-06-01       Impact factor: 4.207

9.  Translation of gastric disease progression at gene level expression.

Authors:  Stephanie Euridice Morales-Guerrero; Claudia Ivette Rivas-Ortiz; Sergio Ponce de León-Rosales; Armando Gamboa-Domínguez; Claudia Rangel-Escareño; Luis Federico Uscanga-Domínguez; Germán Rubén Aguilar-Gutiérrez; David Kershenobich-Stalnikowitz; Gonzalo Castillo-Rojas; Yolanda López-Vidal
Journal:  J Cancer       Date:  2020-01-01       Impact factor: 4.207

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.